GlobalData

Report: Schizophrenia market to rise to $7.3B

Tuesday, November 15, 2016

The schizophrenia market across the seven major markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is set to rise from $6.4 billion in 2015 to $7.3 billion by 2025, registering a compound annual growth rate of 1.4%, according to research and consulting firm GlobalData.

[Read More]

Report: Osteoarthritis space set to approach $10.5B by 2024

Tuesday, September 20, 2016

The osteoarthritis market across the seven major markets of the U.S., France, Germany, Italy, Spain, the U.K., and Japan is forecast to more than treble from $3.25 billion in 2014 to $10.49 billion by 2024, representing a compound annual growth rate of 17.8%, according to research and consulting firm GlobalData.

[Read More]

Report: ADHD market to reach $13.9B by 2024

Wednesday, September 7, 2016

The market for attention deficit hyperactivity disorder (ADHD) across the seven major markets (7MM) of the U.S., France, Germany, Italy, Spain, the U.K. and Japan, is set to experience an increase from approximately $6.1 billion in 2014 to $13.9 billion by 2024, at a compound annual growth rate of 8.5%, according to research and consulting firm GlobalData.

[Read More]